Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Sweeney

Showing results (71-80 of 264) with videos related to

Pageof 27
Sort By:
The Prostate|September 28, 2020
Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancerCecile Vicier, Praful Ravi, Lucia Kwak, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2024
Challenges of estimating treatment effects after a positive interim analysisYu Yang Soon, Ian C Marschner, Manjula Schou, et al.
American Journal of Clinical Oncology|June 28, 2017
Quantifying Decreased Radiation Exposure From Modern CT Scan Technology and Surveillance Programs of Germ Cell TumorsStephanie A Howard, Michael H Rosenthal, Lei Qin, et al.
Cancer|December 22, 2017
Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysisLauren C Harshman, Wanling Xie, Raphael B Moreira, et al.
BJU International|December 16, 2010
Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610Meena Okera, Kyoungwha Bae, Eric Bernstein, et al.
The Prostate|October 18, 2013
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survivalJaya Sharma, Kathryn P Gray, Carolyn Evan, et al.
Cancer Chemotherapy and Pharmacology|November 14, 2009
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairmentChristopher J Sweeney, Chris Takimoto, Leslie Wood, et al.
BJU International|November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancerYu Yang Soon, Ian C Marschner, I Manjula Schou, et al.
Cancer Research|October 3, 2003
Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratomaDavid W Brandli, Thomas M Ulbright, Richard S Foster, et al.
Journal of Proteome Research|April 17, 2007
Alterations in the serum glycome due to metastatic prostate cancerZuzana Kyselova, Yehia Mechref, Mohammad M Al Bataineh, et al.
Pageof 27

Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
The Prostate|September 28, 2020
Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancerCecile Vicier, Praful Ravi, Lucia Kwak, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2024
Challenges of estimating treatment effects after a positive interim analysisYu Yang Soon, Ian C Marschner, Manjula Schou, et al.
American Journal of Clinical Oncology|June 28, 2017
Quantifying Decreased Radiation Exposure From Modern CT Scan Technology and Surveillance Programs of Germ Cell TumorsStephanie A Howard, Michael H Rosenthal, Lei Qin, et al.
Cancer|December 22, 2017
Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysisLauren C Harshman, Wanling Xie, Raphael B Moreira, et al.
BJU International|December 16, 2010
Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610Meena Okera, Kyoungwha Bae, Eric Bernstein, et al.
The Prostate|October 18, 2013
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survivalJaya Sharma, Kathryn P Gray, Carolyn Evan, et al.
Cancer Chemotherapy and Pharmacology|November 14, 2009
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairmentChristopher J Sweeney, Chris Takimoto, Leslie Wood, et al.
BJU International|November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancerYu Yang Soon, Ian C Marschner, I Manjula Schou, et al.
Cancer Research|October 3, 2003
Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratomaDavid W Brandli, Thomas M Ulbright, Richard S Foster, et al.
Journal of Proteome Research|April 17, 2007
Alterations in the serum glycome due to metastatic prostate cancerZuzana Kyselova, Yehia Mechref, Mohammad M Al Bataineh, et al.
Pageof 27